According to the latest report by IMARC Group “Europe Probiotic Supplements Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, The Europe probiotic supplements market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026.
Probiotic supplements are the type of dietary products that include microorganisms as functional ingredients. These supplements are enriched with some common microorganisms such as Lactobacilli, Bifidobacterium, Streptococcus, Saccharomyces Boulardii, etc. As a result, probiotic supplements help in maintaining a healthy balance of gut microbiomes, boosting immunity, reducing inflammatory responses, improving mental health conditions, etc. These supplements are generally available in the forms of food supplements, infant formula, nutritional supplements, specialty nutrients, etc.
Request for a free sample copy of this report: https://www.imarcgroup.com/europe-probiotic-supplements-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
In Europe, the increasing prevalence of various chronic diseases, such as Gastroesophageal Reflux Disease (GERD), Crohn’s disease, gastroenteritis, etc., is primarily propelling the demand for probiotic supplements. Moreover, the escalating geriatric population, who are more prone to such ailments, is also bolstering the market growth in the region. Besides this, the gradual shift in consumer preferences from carbonated drinks towards functional and probiotic beverages is further providing a thrust to the market. Additionally, the launch of several innovative product variants in exotic flavors and attractive packaging is also catalyzing the sales of probiotic supplements in Europe. In the coming years, the changing consumer inclination from chemical additives-based supplements towards organic, natural, and clean-labeled alternatives, including probiotic supplements, will continue to propel the market growth in Europe.
Breakup by Ingredient:
- Saccharomyces Boulardii
Breakup by Form:
Breakup by Application:
- Food Supplements
- Nutritional Supplements
- Speciality Nutrients
- Infant Formula
Breakup by Distribution Channel:
- Supermarkets and Hypermarkets
- Hospitals & Clinics
Breakup by Country:
- United Kingdom
Competitive Landscape with Key Player:
- Bio-K Plus International Inc.
- Chr. Hansen Holding A/S
- Daflorn Probiotics UK
- Danone S.A,
- IPA EUROPE
- PepsiCo Inc.
- Yakult Honsha.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://bit.ly/3h0AQ36
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800